Article info
PDFClinical ethics
Student essay
Informed consent and ECT: how much information should be provided?
- Correspondence to Robert Torrance, School of Medicine and Dentistry, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK; r.torrance.10{at}aberdeen.ac.uk
Citation
Informed consent and ECT: how much information should be provided?
Publication history
- Received October 19, 2013
- Revised May 27, 2014
- Accepted June 4, 2014
- First published June 17, 2014.
Online issue publication
November 16, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Electroconvulsive therapy, the placebo effect and informed consent
- Current status of electroconvulsive therapy for mood disorders: a clinical review
- New guidance on ECT looks set to curb its use
- ‘Delusional’ consent in somatic treatment: the emblematic case of electroconvulsive therapy
- Electroconvulsive therapy: a life course approach for recurrent depressive disorder
- Should we stop using electroconvulsive therapy?
- Electroconvulsive therapy
- Electroconvulsive therapy: the importance of informed consent and ‘placebo literacy’
- Comparative efficacy, cognitive effects and acceptability of electroconvulsive therapies for the treatment of depression: protocol for a systematic review and network meta-analysis
- Catatonic schizophrenia: therapeutic challenges and potentially a new role for electroconvulsive therapy?